NCT00929435

Brief Summary

One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of 1 year will be calculated.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

June 24, 2009

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 29, 2009

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

April 9, 2012

Status Verified

April 1, 2012

Enrollment Period

2.6 years

First QC Date

June 24, 2009

Last Update Submit

April 5, 2012

Conditions

MRSA Colonization

Keywords

MRSAContact isolationIncidence

Outcome Measures

Primary Outcomes (1)

  • To detect an increase in MRSA nasal carriage rate among newly appointed residents after 1 year of regular patient contact.

    1 year

Study Arms (1)

MRSA surveillance

Newly recruited resident physicians will be monitored for a year with nasal swabs monthly.

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All newly recruited residents will be eligible for enrollment.

You may qualify if:

  • Study subjects will be newly appointed residents at the OU medical center

You may not qualify if:

  • Previous MRSA infection
  • Current use of mupirocin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma University health science center

Oklahoma City, Oklahoma, 73104, United States

Location

Study Officials

  • Gary T Kinasewitz, MD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 24, 2009

First Posted

June 29, 2009

Study Start

June 1, 2009

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

April 9, 2012

Record last verified: 2012-04

Locations

US(1)